ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

HK inno.N Corporation clinical trials

Also known as CJ Healthcare.

Part of Kolmar Korea Co., Ltd.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 104 studies whose lead sponsor is HK inno.N Corporation. 19 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare HK inno.N with Eli Lilly and Jiangsu HengRui Medicine →

Pipeline: 9 programs

Each counted once: 9 with a study HK inno.N Corporation leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of HK inno.N Corporation’s own registered studies; HK inno.N Corporation’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs HK inno.N Corporation’s studies test, most open studies first — 25 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 15 more

Coming up

5 of HK inno.N Corporation’s studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. 1J’27
  4. F
  5. M
  6. A
  7. M
  8. 1J
  9. J
  10. 1A
  11. S
  12. O
  13. N

Add all 5 to your calendar (.ics) → With an account.

All 104 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1918%Recruiting 9 · Not yet recruiting 9 · Enrolling by invitation 1
  • Under way, not recruiting22%
  • Completed6462%
  • Stopped early11%
  • Status unknown or other1817%

Phase

  • Phase 164
  • Phase 318
  • Phase 49
  • Phase 26

Where

  • Korea, Republic of88

Over the years

  1. 09
  2. 10
  3. 11
  4. 12
  5. 13
  6. 1014
  7. 15
  8. 16
  9. 17
  10. 18
  11. 19
  12. 20
  13. 21
  14. 22
  15. 23
  16. 24
  17. 25
  18. 526

By the year each study started; 1 started before 2009. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to HK inno.N Corporation.

  • HK inno.N Corporation
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    104 studies

Studies

Recruiting first, then most recently updated. Showing 50 of 104. Browse all 104 →